Not Tagged
rafael pharma
['lymphoma', 'rafael ']
 impact of scholar-1 refractoriness criteria on the efficacy of car-t therapy in aggressive b cell lymphoma, compared with non-refractory patients: a real world geltamo/geth study #ash22 
MD, PhD. Hematologist in CHUAC (A Coruña-Spain). Leukemia,Bone Marrow Transplantation and CAR-T. Tweets and opinions are mine.